Amendment 257 to article 3, paragraph 1, point 5
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – Article 3, § 1, point 5 – Am 257
Adopted
- For
- 325
- Against
- 284
- Abstained
- 33
roll-call vote at 12:46 · 51% of votes cast in favour
Roll call requested by Renew
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 38 | 0 | 0 | 38 | For |
| Greens | 51 | 0 | 0 | 51 | For |
| S&D | 115 | 1 | 2 | 118 | For |
| Renew | 58 | 0 | 8 | 66 | For |
| EPP | 29 | 139 | 7 | 175 | Against |
| ECR | 0 | 64 | 6 | 70 | Against |
| Patriots | 27 | 51 | 0 | 78 | Divided |
| ESN | 0 | 20 | 3 | 23 | Against |
| No group | 7 | 9 | 7 | 23 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
23 MEPs of 642 Clear filters
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.